Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy. Вопр. онкол. 2024, 70 (4), 677-684. https://doi.org/10.37469/0507-3758-2024-70-4-677-684.